Annual Accounts Payable
$4.30 M
+$1.79 M+71.59%
December 31, 2023
Summary
- As of February 7, 2025, CTSO annual accounts payable is $4.30 million, with the most recent change of +$1.79 million (+71.59%) on December 31, 2023.
- During the last 3 years, CTSO annual accounts payable has risen by +$1.83 million (+74.31%).
- CTSO annual accounts payable is now at all-time high.
Performance
CTSO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.34 M
-$708.90 K-23.27%
September 30, 2024
Summary
- As of February 7, 2025, CTSO quarterly accounts payable is $2.34 million, with the most recent change of -$708.90 thousand (-23.27%) on September 30, 2024.
- Over the past year, CTSO quarterly accounts payable has dropped by -$1.10 million (-32.06%).
- CTSO quarterly accounts payable is now -51.55% below its all-time high of $4.83 million, reached on March 31, 2022.
Performance
CTSO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CTSO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +71.6% | -32.1% |
| 3 y3 years | +74.3% | -0.4% |
| 5 y5 years | +118.8% | -0.4% |
CTSO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +71.6% | -51.5% | +9.8% |
| 5 y | 5-year | at high | +74.3% | -51.5% | +39.4% |
| alltime | all time | at high | +536.8% | -51.5% | +7252.5% |
Cytosorbents Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.34 M(-23.3%) |
| Jun 2024 | - | $3.05 M(+27.0%) |
| Mar 2024 | - | $2.40 M(-44.2%) |
| Dec 2023 | $4.30 M(+71.6%) | $4.30 M(+24.9%) |
| Sep 2023 | - | $3.44 M(+21.4%) |
| Jun 2023 | - | $2.84 M(-5.3%) |
| Mar 2023 | - | $2.99 M(+19.5%) |
| Dec 2022 | $2.51 M(-34.9%) | $2.51 M(+6.7%) |
| Sep 2022 | - | $2.35 M(+10.3%) |
| Jun 2022 | - | $2.13 M(-55.9%) |
| Mar 2022 | - | $4.83 M(+25.4%) |
| Dec 2021 | $3.85 M(+56.1%) | $3.85 M(+14.6%) |
| Sep 2021 | - | $3.36 M(+55.0%) |
| Jun 2021 | - | $2.17 M(+29.1%) |
| Mar 2021 | - | $1.68 M(-32.0%) |
| Dec 2020 | $2.47 M(-7.6%) | $2.47 M(+3.4%) |
| Sep 2020 | - | $2.39 M(-12.5%) |
| Jun 2020 | - | $2.73 M(+54.0%) |
| Mar 2020 | - | $1.77 M(-33.7%) |
| Dec 2019 | $2.67 M(+35.8%) | $2.67 M(+28.8%) |
| Sep 2019 | - | $2.07 M(-3.6%) |
| Jun 2019 | - | $2.15 M(+16.8%) |
| Mar 2019 | - | $1.84 M(-6.4%) |
| Dec 2018 | $1.97 M(+26.4%) | $1.97 M(+5.7%) |
| Sep 2018 | - | $1.86 M(+48.3%) |
| Jun 2018 | - | $1.25 M(-41.4%) |
| Mar 2018 | - | $2.14 M(+37.6%) |
| Dec 2017 | $1.55 M(+13.1%) | $1.55 M(+20.7%) |
| Sep 2017 | - | $1.29 M(-18.5%) |
| Jun 2017 | - | $1.58 M(-4.7%) |
| Mar 2017 | - | $1.66 M(+20.7%) |
| Dec 2016 | $1.37 M(+100.8%) | $1.37 M(+85.8%) |
| Sep 2016 | - | $739.90 K(-27.6%) |
| Jun 2016 | - | $1.02 M(+18.7%) |
| Mar 2016 | - | $860.70 K(+25.7%) |
| Dec 2015 | $684.60 K | $684.60 K(+30.0%) |
| Sep 2015 | - | $526.70 K(+26.1%) |
| Jun 2015 | - | $417.70 K(-12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $475.20 K(-31.9%) |
| Dec 2014 | $698.30 K(-11.2%) | $698.30 K(+56.5%) |
| Sep 2014 | - | $446.20 K(-15.2%) |
| Jun 2014 | - | $526.00 K(-0.3%) |
| Mar 2014 | - | $527.60 K(-32.9%) |
| Dec 2013 | $786.50 K(-1.8%) | $786.50 K(+37.5%) |
| Sep 2013 | - | $572.00 K(-20.6%) |
| Jun 2013 | - | $720.60 K(+2.3%) |
| Mar 2013 | - | $704.70 K(-12.0%) |
| Dec 2012 | $800.70 K(+18.6%) | $800.70 K(+10.0%) |
| Sep 2012 | - | $728.00 K(+17.3%) |
| Jun 2012 | - | $620.80 K(-4.1%) |
| Mar 2012 | - | $647.50 K(-4.1%) |
| Dec 2011 | $675.20 K(-17.4%) | $675.20 K(-13.9%) |
| Sep 2011 | - | $784.40 K(-5.8%) |
| Jun 2011 | - | $832.60 K(+8.5%) |
| Mar 2011 | - | $767.20 K(-6.2%) |
| Dec 2010 | $817.70 K(-4.0%) | $817.70 K(-1.3%) |
| Sep 2010 | - | $828.40 K(+1.0%) |
| Jun 2010 | - | $820.20 K(-7.6%) |
| Mar 2010 | - | $888.10 K(+4.2%) |
| Dec 2009 | $852.20 K(-3.8%) | $852.20 K(+5.7%) |
| Sep 2009 | - | $806.20 K(-1.9%) |
| Jun 2009 | - | $821.70 K(+7.0%) |
| Mar 2009 | - | $767.90 K(-13.3%) |
| Dec 2008 | $885.50 K(+14.2%) | $885.50 K(+2.8%) |
| Sep 2008 | - | $861.10 K(-22.9%) |
| Jun 2008 | - | $1.12 M(+22.7%) |
| Mar 2008 | - | $910.10 K(+17.4%) |
| Dec 2007 | $775.30 K(-17.7%) | $775.30 K(+9.8%) |
| Sep 2007 | - | $706.00 K(-12.6%) |
| Jun 2007 | - | $807.60 K(-8.1%) |
| Mar 2007 | - | $879.10 K(-6.7%) |
| Dec 2006 | $942.30 K | $942.30 K(-25.1%) |
| Sep 2006 | - | $1.26 M(-44.8%) |
| Jun 2006 | - | $2.28 M(+5268.0%) |
| Feb 2006 | - | $42.50 K(+18.7%) |
| Nov 2005 | - | $35.80 K(+12.6%) |
| Aug 2005 | - | $31.80 K |
FAQ
- What is Cytosorbents annual accounts payable?
- What is the all time high annual accounts payable for Cytosorbents?
- What is Cytosorbents annual accounts payable year-on-year change?
- What is Cytosorbents quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cytosorbents?
- What is Cytosorbents quarterly accounts payable year-on-year change?
What is Cytosorbents annual accounts payable?
The current annual accounts payable of CTSO is $4.30 M
What is the all time high annual accounts payable for Cytosorbents?
Cytosorbents all-time high annual accounts payable is $4.30 M
What is Cytosorbents annual accounts payable year-on-year change?
Over the past year, CTSO annual accounts payable has changed by +$1.79 M (+71.59%)
What is Cytosorbents quarterly accounts payable?
The current quarterly accounts payable of CTSO is $2.34 M
What is the all time high quarterly accounts payable for Cytosorbents?
Cytosorbents all-time high quarterly accounts payable is $4.83 M
What is Cytosorbents quarterly accounts payable year-on-year change?
Over the past year, CTSO quarterly accounts payable has changed by -$1.10 M (-32.06%)